Firms
Theme

ECPG

Encore Capital Group, Inc. · NASDAQ

News

3 latest

Zacks Investment Research

Encore Capital Stock Soars 73.8% YTD: Is There Further Upside Left?

Encore Capital Group (ECPG) has surged 73.8% YTD, outperforming peers and the S&P 500. The company benefits from robust U.S. portfolio supply, record collections of $1.46B, and raised 2026 guidance for $1.40-$1.50B in purchases and $13-$14 GAAP EPS.

Mentions ECPG

Zacks Investment Research

Sallie Mae (SLM) Reports Q3 Loss, Lags Revenue Estimates

Sallie Mae reported a quarterly loss of $0.19 per share, significantly missing the consensus estimate of $0.12 and declining from $0.63 earnings per share a year ago. The company also missed revenue expectations at $339.32 million versus the estimate of $353.66 million. With a Zacks Rank #3 (Hold) rating and the Financial - Consumer Loans industry ranking in the bottom 26% of industries, the stock is expected to perform in line with the market.

Zacks Investment Research

BankUnited, Inc. (BKU) Q3 Earnings and Revenues Lag Estimates

BankUnited reported Q3 2026 earnings of $1.03 per share, missing the consensus estimate of $1.05, and revenues of $280.44 million, falling short of expectations by 4.16%. The company has underperformed the S&P 500 by 17.8% year-to-date. With unfavorable estimate revision trends, BankUnited received a Zacks Rank #4 (Sell) rating, suggesting near-term underperformance.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $ECPG · 0 threads

Sign in to post on $ECPG

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev